amfAR story
Advances in antiretroviral therapy have transformed HIV from a fatal infection into a manageable chronic condition. As a result, people living with HIV are living longer than ever before—a remarkable success story for science and medicine. But longevity also brings new questions, including how HIV may interact with the biology of aging.
One area drawing growing attention is brain health. How does HIV that has been treated long-term affect cognitive aging? Could it influence the development or progression of neurodegenerative diseases, such as Alzheimer’s?
To explore these questions, Dr. Andrea Gramatica, an immunologist and VP of Research at amfAR, and Dr. Kelsey Hopland, a neuroscientist and new Program Officer, Research, at amfAR, sat down to discuss what scientists currently understand—and what remains unknown—about the intersection of HIV and neurodegeneration.
Read the full discussion here.
